Blog
RSS FeedPosted by Michael Wonder on 14 Jan 2020
It's given me so much hope': PHARMAC announces breast cancer drug deal
15 January 2020 - Wiki Mulholland has watched friends die around her since her terminal breast cancer diagnosis 18 months ...
Posted by Michael Wonder on 14 Jan 2020
PHARMAC seeking views on new breast cancer medicine
15 January 2020 - PHARMAC has reached a provisional agreement with medicine supplier Pfizer to fund palbociclib (marketed as Ibrance) ...
Posted by Michael Wonder on 14 Jan 2020
Coffin drawn through Timaru draws attention to health care 'truth'
14 January 2020 - Camilla and Julian Cox cycled into Timaru on Monday pulling a coffin behind their tandem as ...
Posted by Michael Wonder on 13 Jan 2020
Myeloma NZ calls on PHARMAC to make good on access deal
14 January 2020 - Myeloma New Zealand is today calling on PHARMAC to make good on their proposal to widen ...
Posted by Michael Wonder on 09 Jan 2020
PHARMAC epilepsy drug process questions
10 January 2020 - There are many unanswered questions about PHARMAC's decision to fund only one brand of the epilepsy ...
Posted by Michael Wonder on 05 Jan 2020
'The public deserves to know why' - National intensifies calls for inquiry into PHARMAC after fifth death linked to epilepsy drug Logem
2 January 2020 - The National Party has intensified its call for a ministerial inquiry into PHARMAC's decision to switch ...
Posted by Michael Wonder on 05 Jan 2020
Dunedin couple towing coffin to Parliament in bid to double PHARMAC budget
3 January 2020 - A Dunedin couple is towing a coffin behind a tandem bike to Parliament in a call ...
Posted by Michael Wonder on 03 Jan 2020
PHARMAC - 2019 in review
2 January 2019 - Second lowest annual number of real world new medicines listed in New Zealand Pharmaceutical Schedule over ...
Posted by Michael Wonder on 02 Jan 2020
New Zealand Pharmaceutical Schedule - 1 January 2020 update
2 January 2020 - The January 2020 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 19 Dec 2019
Request for information on lamotrigine brand change
9 December 2019 - The request, dated 15 November 2019, asked for all and any advice or information or guidance that ...
Posted by Michael Wonder on 18 Dec 2019
Proposal to fund mepolizumab for the treatment of severe refractory eosinophilic asthma
18 December 2019 - PHARMAC is seeking feedback on a proposal to fund mepolizumab (Nucala), a new treatment for severe ...
Posted by Michael Wonder on 17 Dec 2019
Comparison of PHARMAC with UK agency was misleading
17 December 2019 - The Broadcasting Standards Authority has upheld part of a complaint that an interview on Radio New ...
Posted by Michael Wonder on 17 Dec 2019
PHARMAC brand switch: man driving through Waterview Tunnel blacked out
18 December 2019 - An Auckland man had a seizure and blacked out as he drove through Auckland's Waterview Tunnel after ...
Posted by Michael Wonder on 17 Dec 2019
Calls for answers about PHARMAC delay after epilepsy deaths
17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...
Posted by Michael Wonder on 17 Dec 2019
Lamotrigine NPPA change
17 December 2019 - The request seeks all ‘communications’ between members of the PHARMAC senior leadership team, and in anticipation ...